NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (Library Prep, Target Enrichment), Sample Type (DNA), Application (Diagnostics, Drug Discovery), Method (Microfluidic, Automated), End User & Region - Global Forecast to 2028
The NGS sample preparation market is projected to reach USD 4.0 billion by 2028 from USD 1.9 billion in 2022, at a CAGR of 13.4% during the forecast period. The key factors driving the growth of the NGS sample preparation market are constant innovations in NGS platforms, and increased availability of advanced NGS systems at low costs. However, the presence of alternative technologies is expected to restrain market growth to a certain extent.
The NGS sample preparation market has been segmented based on products & services, workflow, sample type, method, application, end user, and region.
“By application, the disease diagnostics accounted for the largest share of the NGS sample preparation market”
Based on application, the NGS sample preparation market is categorized into disease diagnostics, drug discovery, agricultural & animal research, and others. The disease diagnostics segment dominated the market in 2022, owing to favorable reimbursement scenario for NGS-based tests and increasing focus of key players on developing NGS-based products & services for cancer and NIPT are the key factors driving the growth of the segment.
“By end user, the academic institutes & research centers accounted for the largest share in the NGS Sample Preparation market”
Based on end user, the NGS sample preparation market is segmented into hospitals & clinics, academic institutes & research centers, pharmaceutical & biotechnology companies, and other end users. In 2022, the academic institutes & research centers segment accounted for a larger share of the NGS sample preparation market. Growth in this market segment can be attributed to availability of financial support for genomics R&D across regions, and the development of cost-effective NGS products & services for researchers.
“North America: the largest share of the NGS sample preparation market”
North America accounted for the largest share of the NGS sample preparation market. Favorable initiatives by government and private bodies for the adoption of NGS technologies, advancements in NGS sample preparation products, the growing prevalence of target diseases, an increasing number of NGS-based research & clinical applications, growing research on cancer, the rising awareness of NGS services, and the presence of leading NGS service providers, such as Illumina (US), Thermo Fisher Scientific (US), and Agilent Technologies (US), are driving the growth of the NGS sample preparation market in North America.
“Asia Pacific: The fastest-growing region in the NGS sample preparation market.”
The Asia Pacific NGS sample preparation market is projected to grow at the highest CAGR during the forecast period, mainly due to significant focus on R&D activities as a means of broadening the scope of NGS applications, the increasing adoption of NGS for diagnostics due to the decreasing cost of NGS products and services, and technological development in NGS data analysis. In addition, a number of domestic and international market players focus on strengthening their presence in the Asia Pacific NGS market, while domestic players expand their international reach through partnerships, collaborations, agreements, and expansions.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the NGS sample preparation market. It aims at estimating the size and future growth potential of the market across different segments, such as the product & services, workflow, sample type, method, applications, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NGS sample preparation market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
The NGS sample preparation market has been segmented based on products & services, workflow, sample type, method, application, end user, and region.
“By application, the disease diagnostics accounted for the largest share of the NGS sample preparation market”
Based on application, the NGS sample preparation market is categorized into disease diagnostics, drug discovery, agricultural & animal research, and others. The disease diagnostics segment dominated the market in 2022, owing to favorable reimbursement scenario for NGS-based tests and increasing focus of key players on developing NGS-based products & services for cancer and NIPT are the key factors driving the growth of the segment.
“By end user, the academic institutes & research centers accounted for the largest share in the NGS Sample Preparation market”
Based on end user, the NGS sample preparation market is segmented into hospitals & clinics, academic institutes & research centers, pharmaceutical & biotechnology companies, and other end users. In 2022, the academic institutes & research centers segment accounted for a larger share of the NGS sample preparation market. Growth in this market segment can be attributed to availability of financial support for genomics R&D across regions, and the development of cost-effective NGS products & services for researchers.
“North America: the largest share of the NGS sample preparation market”
North America accounted for the largest share of the NGS sample preparation market. Favorable initiatives by government and private bodies for the adoption of NGS technologies, advancements in NGS sample preparation products, the growing prevalence of target diseases, an increasing number of NGS-based research & clinical applications, growing research on cancer, the rising awareness of NGS services, and the presence of leading NGS service providers, such as Illumina (US), Thermo Fisher Scientific (US), and Agilent Technologies (US), are driving the growth of the NGS sample preparation market in North America.
“Asia Pacific: The fastest-growing region in the NGS sample preparation market.”
The Asia Pacific NGS sample preparation market is projected to grow at the highest CAGR during the forecast period, mainly due to significant focus on R&D activities as a means of broadening the scope of NGS applications, the increasing adoption of NGS for diagnostics due to the decreasing cost of NGS products and services, and technological development in NGS data analysis. In addition, a number of domestic and international market players focus on strengthening their presence in the Asia Pacific NGS market, while domestic players expand their international reach through partnerships, collaborations, agreements, and expansions.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 60% and Demand Side 40%
- By Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%
- By Country: North America- 22%, Europe- 42%, Asia Pacific- 11%, Latin America- 20%, and MEA- 5%
- Illumina, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- PerkinElmer Inc. (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Agilent Technologies, Inc. (US)
- Danaher (US)
- Becton, Dickinson and Company (US)
- Merck KGAA (Germany)
- QIAGEN (Germany)
- Bio-Rad Laboratories, Inc. (US)
- Promega Corporation (US)
- Eurofins Scientific (Luxembourg)
- BGI (China)
- 10x Genomics (US)
- Sysmex Corporation (US)
- Psomagen (US)
- Zymo Research Corporation (US)
- Takara Bio Inc. (Japan)
- Novogene Co., Ltd. (China)
- New England Biolabs (US)
- Tecan Trading AG (US)
- Oxford Nanopore Technologies PLC (UK)
- PacBio (US)
- Medgenome (US)
- Swift Biosciences Inc. (US)
This report provides a detailed picture of the NGS sample preparation market. It aims at estimating the size and future growth potential of the market across different segments, such as the product & services, workflow, sample type, method, applications, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NGS sample preparation market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 RESEARCH LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS), 2021
FIGURE 4 NGS SAMPLE PREPARATION MARKET SIZE (USD MILLION)
FIGURE 5 NGS SAMPLE PREPARATION MARKET: FINAL CAGR PROJECTIONS (2023?2028)
FIGURE 6 NGS SAMPLE PREPARATION MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 INDUSTRY INSIGHTS
2.5 STUDY ASSUMPTIONS
2.6 GLOBAL RECESSION IMPACT: NGS SAMPLE PREPARATION MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 8 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2022 VS. 2028 (USD MILLION)
FIGURE 9 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2022 VS. 2028 (USD MILLION)
FIGURE 10 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2022 VS. 2028 (USD MILLION)
FIGURE 11 NGS SAMPLE PREPARATION MARKET, BY METHOD, 2022 VS. 2028 (USD MILLION)
FIGURE 12 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2022 VS. 2028 (USD MILLION)
FIGURE 13 NGS SAMPLE PREPARATION MARKET, BY END USER, 2022 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NGS SAMPLE PREPARATION MARKET
4 PREMIUM INSIGHTS
4.1 NGS SAMPLE PREPARATION MARKET OVERVIEW
FIGURE 15 ADVANCEMENTS IN NGS PLATFORMS TO DRIVE GROWTH
4.2 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 16 REAGENTS & CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2022 VS. 2028
FIGURE 17 DISEASE DIAGNOSTICS SEGMENT TO DOMINATE MARKET IN 2028
4.4 NGS SAMPLE PREPARATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 NGS SAMPLE PREPARATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 NGS SAMPLE PREPARATION MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Constant innovations in NGS platforms
5.2.1.2 Increased availability of advanced NGS systems at low costs
FIGURE 20 COST PER HUMAN GENOME, 2001–2021
5.2.1.3 Use of NGS as substitute for PCR
5.2.1.4 Greater efficiency of genotyping and preparation protocols
5.2.2 RESTRAINTS
5.2.2.1 Presence of alternative technologies
5.2.2.2 Limited expertise and sequencing capabilities of individual laboratories
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing collaborations and partnerships among key players
5.2.4 CHALLENGES
5.2.4.1 Ethical and privacy issues in health data
5.3 TECHNOLOGY ANALYSIS
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 SUPPLY AND VALUE CHAIN ANALYSIS
5.5.1 SUPPLY CHAIN ANALYSIS OF NGS SAMPLE PREPARATION MARKET
FIGURE 22 NGS SAMPLE PREPARATION MARKET: SUPPLY CHAIN ANALYSIS
5.5.2 VALUE CHAIN ANALYSIS OF NGS SAMPLE PREPARATION MARKET
FIGURE 23 NGS SAMPLE PREPARATION MARKET: VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
FIGURE 24 NGS SAMPLE PREPARATION MARKET: ECOSYSTEM ANALYSIS
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 5 NGS SAMPLE PREPARATION MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 REGULATORY ANALYSIS
5.8.1 FDA APPROVALS
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9 PRICING ANALYSIS
TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
5.9.1 AVERAGE SELLING PRICE TREND ANALYSIS
5.10 PATENT ANALYSIS
FIGURE 25 PATENT FILING TRENDS FOR TOP 5 IPC MAIN CLASSES, 2018?2020
5.11 KEY CONFERENCES AND EVENTS IN 2023
5.11.1 CONFERENCES ON NGS SAMPLE PREPARATION IN 2023
TABLE 11 CONFERENCES ON NGS SAMPLE PREPARATION (2023)
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN NGS SAMPLE PREPARATION MARKET
5.12.2 BUYING CRITERIA FOR NGS SAMPLE PREPARATION MARKET
FIGURE 27 KEY BUYING CRITERIA FOR END USERS
6 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 12 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 WORKSTATIONS/INSTRUMENTS
6.2.1 INCREASING DEMAND FOR AUTOMATION OF NGS TO PROPEL MARKET
TABLE 13 NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 14 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 15 EUROPE: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 16 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 17 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 REAGENTS & CONSUMABLES
6.3.1 GROWING USE OF CONSUMABLES FOR NGS SAMPLE PREPARATION TO DRIVE MARKET
TABLE 18 NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 19 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 EUROPE: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SERVICES
6.4.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT MARKET
TABLE 23 NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION)
TABLE 24 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 EUROPE: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
7 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW
7.1 INTRODUCTION
TABLE 28 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
7.2 DNA FRAGMENTATION & LIBRARY PREPARATION
7.2.1 AVAILABILITY OF PRODUCTS FROM VARIOUS PLAYERS TO DRIVE MARKET
TABLE 29 NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 TARGET ENRICHMENT
7.3.1 LAUNCH OF ADVANCED TARGET ENRICHMENT SOLUTIONS AND TECHNOLOGIES TO DRIVE MARKET
TABLE 34 NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 QUALITY CONTROL
7.4.1 RISING NUMBER OF RESEARCH ACTIVITIES REQUIRING QUALITY-ASSURED SAMPLES TO PROPEL MARKET
TABLE 39 NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY REGION, 2021–2028 (USD MILLION)
TABLE 40 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 EUROPE: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION)
8 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE
8.1 INTRODUCTION
TABLE 44 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
8.2 DNA
8.2.1 RISING NUMBER OF CANCER CASES AND GROWING R&D INVESTMENTS FOR STUDYING DNA SAMPLES TO DRIVE MARKET
TABLE 45 NGS SAMPLE PREPARATION MARKET FOR DNA, BY REGION, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 RNA
8.3.1 DECREASED COSTS OF GENOME SEQUENCING TO AUGMENT MARKET
TABLE 50 NGS SAMPLE PREPARATION MARKET FOR RNA, BY REGION, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION)
9 NGS SAMPLE PREPARATION MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 55 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2 DISEASE DIAGNOSTICS
TABLE 56 NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 57 NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 58 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 59 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 60 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
9.2.1 CANCER DIAGNOSTICS
9.2.1.1 Increase in cancer patients globally and launch of NGS-based cancer panels to drive market
TABLE 62 CANCER DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 63 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.2.2 REPRODUCTIVE HEALTH DIAGNOSTICS
9.2.2.1 Increasing awareness about benefits of NIPT and decreasing costs of sequencing to propel market
TABLE 67 REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 68 NORTH AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 EUROPE: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 ASIA PACIFIC: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 LATIN AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.2.3 INFECTIOUS DISEASE DIAGNOSTICS
9.2.3.1 Growing burden of healthcare-associated infections to aid market
TABLE 72 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 76 LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.2.4 OTHER DISEASE DIAGNOSTIC APPLICATIONS
TABLE 77 OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 78 NORTH AMERICA: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 EUROPE: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 81 LATIN AMERICA: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 DRUG DISCOVERY
9.3.1 INCREASING USE OF NGS DURING CLINICAL TRIALS TO AUGMENT MARKET
TABLE 82 NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION)
TABLE 83 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 85 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 AGRICULTURAL & ANIMAL RESEARCH
9.4.1 INCREASED FUNDING AND SUPPORT FOR ANIMAL AND PLANT GENOMICS RESEARCH TO FUEL ADOPTION
TABLE 87 NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 88 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 EUROPE: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 OTHER APPLICATIONS
TABLE 92 NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 93 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 EUROPE: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
10 NGS SAMPLE PREPARATION MARKET, BY METHOD
10.1 INTRODUCTION
TABLE 97 NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
10.2 MANUAL SAMPLE PREPARATION
10.2.1 ERRORS ASSOCIATED WITH NGS MANUAL SAMPLE PREPARATION TO HINDER MARKET
TABLE 98 NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 EUROPE: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 102 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 MICROFLUIDIC SAMPLE PREPARATION
10.3.1 GROWING APPLICATIONS OF MICROFLUIDIC SAMPLE PREPARATION TO CREATE OPPORTUNITIES
TABLE 103 NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 104 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 EUROPE: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 106 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
10.4 AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION
10.4.1 HIGH PERFORMANCE AND ACCURACY OF AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION TO BOOST GROWTH
TABLE 108 NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 109 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
11 NGS SAMPLE PREPARATION MARKET, BY END USER
11.1 INTRODUCTION
TABLE 113 NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2 HOSPITALS & CLINICS
11.2.1 ADVANTAGES OF NGS TECHNOLOGY FOR DISEASE DIAGNOSIS OVER CONVENTIONAL METHOD TO FUEL ADOPTION
TABLE 114 NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 115 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 116 EUROPE: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
11.3 ACADEMIC INSTITUTES & RESEARCH CENTERS
11.3.1 AVAILABILITY OF FINANCIAL SUPPORT FOR GENOMICS RESEARCH TO SUPPORT SEGMENT
TABLE 119 NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 120 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 EUROPE: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 123 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.4.1 GROWING COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE GROWTH
TABLE 124 NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 125 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 EUROPE: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 128 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
11.5 OTHER END USERS
TABLE 129 NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 130 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 EUROPE: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 133 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
12 NGS SAMPLE PREPARATION MARKET, BY REGION
12.1 INTRODUCTION
FIGURE 28 NGS SAMPLE PREPARATION MARKET, BY REGION, 2021 VS. 2028 (USD MILLION)
TABLE 134 NGS SAMPLE PREPARATION MARKET, BY REGION, 2021–2028 (USD MILLION)
12.2 NORTH AMERICA
FIGURE 29 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET SNAPSHOT
TABLE 135 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 137 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 138 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028
TABLE 139 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028
TABLE 140 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028
TABLE 141 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028
TABLE 142 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028
12.2.1 US
12.2.1.1 Favorable regulatory and reimbursement scenarios to drive market
TABLE 143 US: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 144 US: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 145 US: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 146 US: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 147 US: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 148 US: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 US: NGS SAMPLE PREPARATION MARKET BY END USER, 2021–2028 (USD MILLION)
12.2.2 CANADA
12.2.2.1 Favorable government funding to boost genomics research
TABLE 150 CANADA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 151 CANADA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 152 CANADA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 153 CANADA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 154 CANADA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 155 CANADA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 CANADA: NGS SAMPLE PREPARATION MARKET, FOR END USER, 2021–2028 (USD MILLION)
12.2.3 NORTH AMERICA: IMPACT OF RECESSION
12.3 EUROPE
TABLE 157 EUROPE: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 158 EUROPE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 159 EUROPE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 160 EUROPE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 161 EUROPE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 162 EUROPE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 163 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 164 EUROPE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.1 GERMANY
12.3.1.1 Strong R&D base and presence of several NGS players to support market
TABLE 165 GERMANY: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 166 GERMANY: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 167 GERMANY: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 168 GERMANY: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 169 GERMANY: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 170 GERMANY: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 171 GERMANY: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.2 UK
12.3.2.1 Use of NGS-based tests for disease diagnosis to augment market
TABLE 172 UK: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 173 UK: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 174 UK NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 175 UK NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 176 UK: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 177 UK: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 UK: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.3 FRANCE
12.3.3.1 Growing government support for genomics research to propel market
TABLE 179 FRANCE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 180 FRANCE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 181 FRANCE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 182 FRANCE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 183 FRANCE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 184 FRANCE: NGS SAMPLE PREPARATION MARKET BY DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 185 FRANCE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.4 REST OF EUROPE
TABLE 186 REST OF EUROPE NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 187 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 188 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 189 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 190 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 191 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 192 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.5 EUROPE: IMPACT OF RECESSION
12.4 ASIA PACIFIC
FIGURE 30 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET SNAPSHOT
TABLE 193 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 194 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 195 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 196 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 197 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 198 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 199 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 200 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.1 CHINA
12.4.1.1 Favorable government initiatives for advanced life science research to aid market
TABLE 201 CHINA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 202 CHINA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 203 CHINA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 204 CHINA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 205 CHINA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 206 CHINA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 207 CHINA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.2 JAPAN
12.4.2.1 Increased research funding to create growth opportunities for NGS-based studies
TABLE 208 JAPAN: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 209 JAPAN: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 210 JAPAN: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 211 JAPAN: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 212 JAPAN: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 213 JAPAN: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 214 JAPAN: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.3 INDIA
12.4.3.1 Decreasing sequencing costs and growing prevalence of target diseases to support market
TABLE 215 INDIA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 216 INDIA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 217 INDIA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 218 INDIA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 219 INDIA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 220 INDIA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 221 INDIA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.4 AUSTRALIA
12.4.4.1 Increasing use of NGS platforms by academic institutes to propel market
TABLE 222 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 223 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 224 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 225 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 226 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 227 AUSTRALIA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 228 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.5 SOUTH KOREA
12.4.5.1 Increasing spending by government on NGS research to augment market
TABLE 229 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 230 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 231 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 232 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 233 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 234 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.6 REST OF ASIA PACIFIC
TABLE 236 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 237 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 238 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 239 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 240 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 241 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 242 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.7 ASIA PACIFIC: IMPACT OF RECESSION
12.5 LATIN AMERICA
TABLE 243 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 244 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 245 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 246 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 247 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 248 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 249 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 250 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.1 BRAZIL
12.5.1.1 Rising focus on clinical genomics to drive demand for NGS
TABLE 251 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 252 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 253 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 254 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 255 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 256 BRAZIL: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 257 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.2 MEXICO
12.5.2.1 Growing biotechnology infrastructure development to support market
TABLE 258 MEXICO: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 259 MEXICO: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 260 MEXICO: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 261 MEXICO: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 262 MEXICO: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 263 MEXICO: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 264 MEXICO: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.3 REST OF LATIN AMERICA
TABLE 265 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 266 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 267 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 268 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 269 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 270 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 271 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.4 LATIN AMERICA: IMPACT OF RECESSION
12.6 MIDDLE EAST & AFRICA
12.6.1 INTRODUCTION OF COST-EFFECTIVE AND PORTABLE NGS TECHNOLOGIES TO STIMULATE MARKET
TABLE 272 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 273 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 274 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 275 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 276 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 277 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 278 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY STRATEGIES ADOPTED BY MARKET PLAYERS
TABLE 279 NGS SAMPLE PREPARATION MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
13.3 REVENUE SHARE ANALYSIS (TOP 5 PLAYERS)
FIGURE 31 REVENUE ANALYSIS FOR TOP 5 COMPANIES (2019?2021)
13.4 MARKET SHARE ANALYSIS (2022)
FIGURE 32 NGS SAMPLE PREPARATION MARKET: MARKET SHARE ANALYSIS OF TOP 5 PLAYERS (2022)
13.5 COMPANY EVALUATION QUADRANT
FIGURE 33 NGS SAMPLE PREPARATION MARKET: COMPANY EVALUATION MATRIX (2022)
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
13.6.1 PROGRESSIVE COMPANIES
13.6.2 STARTING BLOCKS
13.6.3 RESPONSIVE COMPANIES
13.6.4 DYNAMIC COMPANIES
FIGURE 34 NGS SAMPLE PREPARATION MARKET: START-UPS/SMES EVALUATION QUADRANT (2022)
13.7 COMPETITIVE BENCHMARKING
13.7.1 DETAILED LIST OF START-UPS/SMES
TABLE 280 NGS SAMPLE PREPARATION MARKET: DETAILED LIST OF START-UPS/SMES
13.7.2 COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES)
TABLE 281 NGS SAMPLE PREPARATION MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES]
13.8 COMPETITIVE SCENARIO AND TRENDS
13.8.1 KEY DEALS
TABLE 282 NGS SAMPLE PREPARATION MARKET: KEY DEALS
13.8.2 KEY PRODUCT LAUNCHES
TABLE 283 NGS SAMPLE PREPARATION MARKET: KEY PRODUCT LAUNCHES
13.8.3 KEY EXPANSIONS
TABLE 284 NGS SAMPLE PREPARATION MARKET: KEY EXPANSIONS
14 COMPANY PROFILES
14.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 ILLUMINA, INC.
TABLE 285 ILLUMINA, INC.: COMPANY OVERVIEW
FIGURE 35 ILLUMINA, INC.: COMPANY SNAPSHOT (2021)
14.1.2 THERMO FISHER SCIENTIFIC INC.
TABLE 286 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
14.1.3 F. HOFFMANN-LA ROCHE LTD.
TABLE 287 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
14.1.4 PERKINELMER INC.
TABLE 288 PERKINELMER INC.: COMPANY OVERVIEW
FIGURE 38 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
14.1.5 AGILENT TECHNOLOGIES, INC.
TABLE 289 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
14.1.6 DANAHER
TABLE 290 DANAHER: COMPANY OVERVIEW
14.1.7 BECTON, DICKINSON AND COMPANY
TABLE 291 BECTON, DICKINSON, AND COMPANY: COMPANY OVERVIEW
FIGURE 41 BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT (2021)
14.1.8 QIAGEN
TABLE 292 QIAGEN: COMPANY OVERVIEW
FIGURE 42 QIAGEN: COMPANY SNAPSHOT (2021)
14.1.9 MERCK KGAA
TABLE 293 MERCK KGAA: COMPANY OVERVIEW
FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT (2021)
14.1.10 BIO-RAD LABORATORIES, INC.
TABLE 294 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
14.1.11 PROMEGA CORPORATION
TABLE 295 PROMEGA CORPORATION: COMPANY OVERVIEW
14.1.12 EUROFINS SCIENTIFIC
TABLE 296 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
FIGURE 45 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
14.1.13 BGI
TABLE 297 BGI: COMPANY OVERVIEW
14.1.14 10X GENOMICS
TABLE 298 10X GENOMICS: COMPANY OVERVIEW
FIGURE 46 10X GENOMICS: COMPANY SNAPSHOT (2021)
14.1.15 SYSMEX CORPORATION
TABLE 299 SYSMEX CORPORATION: COMPANY OVERVIEW
FIGURE 47 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
14.2 OTHER PLAYERS
14.2.1 PSOMAGEN
14.2.2 ZYMO RESEARCH CORPORATION
14.2.3 TAKARA BIO INC.
14.2.4 NOVOGENE CO., LTD.
14.2.5 NEW ENGLAND BIOLABS
14.2.6 TECAN TRADING AG
14.2.7 OXFORD NANOPORE TECHNOLOGIES PLC
14.2.8 PACBIO
14.2.9 MEDGENOME
14.2.10 SWIFT BIOSCIENCES INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 DISCUSSION GUIDE
15.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.2 CUSTOMIZATION OPTIONS
15.3 RELATED REPORTS
15.4 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 RESEARCH LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS), 2021
FIGURE 4 NGS SAMPLE PREPARATION MARKET SIZE (USD MILLION)
FIGURE 5 NGS SAMPLE PREPARATION MARKET: FINAL CAGR PROJECTIONS (2023?2028)
FIGURE 6 NGS SAMPLE PREPARATION MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 INDUSTRY INSIGHTS
2.5 STUDY ASSUMPTIONS
2.6 GLOBAL RECESSION IMPACT: NGS SAMPLE PREPARATION MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 8 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2022 VS. 2028 (USD MILLION)
FIGURE 9 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2022 VS. 2028 (USD MILLION)
FIGURE 10 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2022 VS. 2028 (USD MILLION)
FIGURE 11 NGS SAMPLE PREPARATION MARKET, BY METHOD, 2022 VS. 2028 (USD MILLION)
FIGURE 12 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2022 VS. 2028 (USD MILLION)
FIGURE 13 NGS SAMPLE PREPARATION MARKET, BY END USER, 2022 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NGS SAMPLE PREPARATION MARKET
4 PREMIUM INSIGHTS
4.1 NGS SAMPLE PREPARATION MARKET OVERVIEW
FIGURE 15 ADVANCEMENTS IN NGS PLATFORMS TO DRIVE GROWTH
4.2 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 16 REAGENTS & CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2022 VS. 2028
FIGURE 17 DISEASE DIAGNOSTICS SEGMENT TO DOMINATE MARKET IN 2028
4.4 NGS SAMPLE PREPARATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 NGS SAMPLE PREPARATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 NGS SAMPLE PREPARATION MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Constant innovations in NGS platforms
5.2.1.2 Increased availability of advanced NGS systems at low costs
FIGURE 20 COST PER HUMAN GENOME, 2001–2021
5.2.1.3 Use of NGS as substitute for PCR
5.2.1.4 Greater efficiency of genotyping and preparation protocols
5.2.2 RESTRAINTS
5.2.2.1 Presence of alternative technologies
5.2.2.2 Limited expertise and sequencing capabilities of individual laboratories
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing collaborations and partnerships among key players
5.2.4 CHALLENGES
5.2.4.1 Ethical and privacy issues in health data
5.3 TECHNOLOGY ANALYSIS
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 SUPPLY AND VALUE CHAIN ANALYSIS
5.5.1 SUPPLY CHAIN ANALYSIS OF NGS SAMPLE PREPARATION MARKET
FIGURE 22 NGS SAMPLE PREPARATION MARKET: SUPPLY CHAIN ANALYSIS
5.5.2 VALUE CHAIN ANALYSIS OF NGS SAMPLE PREPARATION MARKET
FIGURE 23 NGS SAMPLE PREPARATION MARKET: VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
FIGURE 24 NGS SAMPLE PREPARATION MARKET: ECOSYSTEM ANALYSIS
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 5 NGS SAMPLE PREPARATION MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 REGULATORY ANALYSIS
5.8.1 FDA APPROVALS
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9 PRICING ANALYSIS
TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
5.9.1 AVERAGE SELLING PRICE TREND ANALYSIS
5.10 PATENT ANALYSIS
FIGURE 25 PATENT FILING TRENDS FOR TOP 5 IPC MAIN CLASSES, 2018?2020
5.11 KEY CONFERENCES AND EVENTS IN 2023
5.11.1 CONFERENCES ON NGS SAMPLE PREPARATION IN 2023
TABLE 11 CONFERENCES ON NGS SAMPLE PREPARATION (2023)
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN NGS SAMPLE PREPARATION MARKET
5.12.2 BUYING CRITERIA FOR NGS SAMPLE PREPARATION MARKET
FIGURE 27 KEY BUYING CRITERIA FOR END USERS
6 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 12 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 WORKSTATIONS/INSTRUMENTS
6.2.1 INCREASING DEMAND FOR AUTOMATION OF NGS TO PROPEL MARKET
TABLE 13 NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 14 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 15 EUROPE: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 16 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 17 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 REAGENTS & CONSUMABLES
6.3.1 GROWING USE OF CONSUMABLES FOR NGS SAMPLE PREPARATION TO DRIVE MARKET
TABLE 18 NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 19 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 EUROPE: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SERVICES
6.4.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT MARKET
TABLE 23 NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION)
TABLE 24 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 EUROPE: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
7 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW
7.1 INTRODUCTION
TABLE 28 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
7.2 DNA FRAGMENTATION & LIBRARY PREPARATION
7.2.1 AVAILABILITY OF PRODUCTS FROM VARIOUS PLAYERS TO DRIVE MARKET
TABLE 29 NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 TARGET ENRICHMENT
7.3.1 LAUNCH OF ADVANCED TARGET ENRICHMENT SOLUTIONS AND TECHNOLOGIES TO DRIVE MARKET
TABLE 34 NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 EUROPE: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 QUALITY CONTROL
7.4.1 RISING NUMBER OF RESEARCH ACTIVITIES REQUIRING QUALITY-ASSURED SAMPLES TO PROPEL MARKET
TABLE 39 NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY REGION, 2021–2028 (USD MILLION)
TABLE 40 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 EUROPE: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION)
8 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE
8.1 INTRODUCTION
TABLE 44 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
8.2 DNA
8.2.1 RISING NUMBER OF CANCER CASES AND GROWING R&D INVESTMENTS FOR STUDYING DNA SAMPLES TO DRIVE MARKET
TABLE 45 NGS SAMPLE PREPARATION MARKET FOR DNA, BY REGION, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 RNA
8.3.1 DECREASED COSTS OF GENOME SEQUENCING TO AUGMENT MARKET
TABLE 50 NGS SAMPLE PREPARATION MARKET FOR RNA, BY REGION, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION)
9 NGS SAMPLE PREPARATION MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 55 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2 DISEASE DIAGNOSTICS
TABLE 56 NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 57 NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 58 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 59 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 60 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
9.2.1 CANCER DIAGNOSTICS
9.2.1.1 Increase in cancer patients globally and launch of NGS-based cancer panels to drive market
TABLE 62 CANCER DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 63 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 65 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.2.2 REPRODUCTIVE HEALTH DIAGNOSTICS
9.2.2.1 Increasing awareness about benefits of NIPT and decreasing costs of sequencing to propel market
TABLE 67 REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 68 NORTH AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 EUROPE: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 ASIA PACIFIC: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 LATIN AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.2.3 INFECTIOUS DISEASE DIAGNOSTICS
9.2.3.1 Growing burden of healthcare-associated infections to aid market
TABLE 72 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 76 LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.2.4 OTHER DISEASE DIAGNOSTIC APPLICATIONS
TABLE 77 OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 78 NORTH AMERICA: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 EUROPE: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 ASIA PACIFIC: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 81 LATIN AMERICA: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 DRUG DISCOVERY
9.3.1 INCREASING USE OF NGS DURING CLINICAL TRIALS TO AUGMENT MARKET
TABLE 82 NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION)
TABLE 83 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 85 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 AGRICULTURAL & ANIMAL RESEARCH
9.4.1 INCREASED FUNDING AND SUPPORT FOR ANIMAL AND PLANT GENOMICS RESEARCH TO FUEL ADOPTION
TABLE 87 NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 88 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 EUROPE: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 91 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
9.5 OTHER APPLICATIONS
TABLE 92 NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 93 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 EUROPE: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 96 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
10 NGS SAMPLE PREPARATION MARKET, BY METHOD
10.1 INTRODUCTION
TABLE 97 NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
10.2 MANUAL SAMPLE PREPARATION
10.2.1 ERRORS ASSOCIATED WITH NGS MANUAL SAMPLE PREPARATION TO HINDER MARKET
TABLE 98 NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 EUROPE: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 102 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 MICROFLUIDIC SAMPLE PREPARATION
10.3.1 GROWING APPLICATIONS OF MICROFLUIDIC SAMPLE PREPARATION TO CREATE OPPORTUNITIES
TABLE 103 NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 104 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 EUROPE: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 106 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
10.4 AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION
10.4.1 HIGH PERFORMANCE AND ACCURACY OF AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION TO BOOST GROWTH
TABLE 108 NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 109 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION)
11 NGS SAMPLE PREPARATION MARKET, BY END USER
11.1 INTRODUCTION
TABLE 113 NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2 HOSPITALS & CLINICS
11.2.1 ADVANTAGES OF NGS TECHNOLOGY FOR DISEASE DIAGNOSIS OVER CONVENTIONAL METHOD TO FUEL ADOPTION
TABLE 114 NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION)
TABLE 115 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 116 EUROPE: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
11.3 ACADEMIC INSTITUTES & RESEARCH CENTERS
11.3.1 AVAILABILITY OF FINANCIAL SUPPORT FOR GENOMICS RESEARCH TO SUPPORT SEGMENT
TABLE 119 NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 120 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 EUROPE: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 123 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.4.1 GROWING COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE GROWTH
TABLE 124 NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 125 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 EUROPE: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 128 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
11.5 OTHER END USERS
TABLE 129 NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 130 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 EUROPE: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 133 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
12 NGS SAMPLE PREPARATION MARKET, BY REGION
12.1 INTRODUCTION
FIGURE 28 NGS SAMPLE PREPARATION MARKET, BY REGION, 2021 VS. 2028 (USD MILLION)
TABLE 134 NGS SAMPLE PREPARATION MARKET, BY REGION, 2021–2028 (USD MILLION)
12.2 NORTH AMERICA
FIGURE 29 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET SNAPSHOT
TABLE 135 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 137 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 138 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028
TABLE 139 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028
TABLE 140 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028
TABLE 141 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028
TABLE 142 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028
12.2.1 US
12.2.1.1 Favorable regulatory and reimbursement scenarios to drive market
TABLE 143 US: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 144 US: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 145 US: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 146 US: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 147 US: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 148 US: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 US: NGS SAMPLE PREPARATION MARKET BY END USER, 2021–2028 (USD MILLION)
12.2.2 CANADA
12.2.2.1 Favorable government funding to boost genomics research
TABLE 150 CANADA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 151 CANADA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 152 CANADA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 153 CANADA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 154 CANADA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 155 CANADA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 CANADA: NGS SAMPLE PREPARATION MARKET, FOR END USER, 2021–2028 (USD MILLION)
12.2.3 NORTH AMERICA: IMPACT OF RECESSION
12.3 EUROPE
TABLE 157 EUROPE: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 158 EUROPE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 159 EUROPE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 160 EUROPE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 161 EUROPE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 162 EUROPE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 163 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 164 EUROPE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.1 GERMANY
12.3.1.1 Strong R&D base and presence of several NGS players to support market
TABLE 165 GERMANY: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 166 GERMANY: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 167 GERMANY: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 168 GERMANY: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 169 GERMANY: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 170 GERMANY: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 171 GERMANY: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.2 UK
12.3.2.1 Use of NGS-based tests for disease diagnosis to augment market
TABLE 172 UK: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 173 UK: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 174 UK NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 175 UK NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 176 UK: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 177 UK: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 UK: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.3 FRANCE
12.3.3.1 Growing government support for genomics research to propel market
TABLE 179 FRANCE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 180 FRANCE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 181 FRANCE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 182 FRANCE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 183 FRANCE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 184 FRANCE: NGS SAMPLE PREPARATION MARKET BY DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 185 FRANCE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.4 REST OF EUROPE
TABLE 186 REST OF EUROPE NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 187 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 188 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 189 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 190 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 191 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 192 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.5 EUROPE: IMPACT OF RECESSION
12.4 ASIA PACIFIC
FIGURE 30 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET SNAPSHOT
TABLE 193 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 194 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 195 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 196 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 197 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 198 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 199 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 200 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.1 CHINA
12.4.1.1 Favorable government initiatives for advanced life science research to aid market
TABLE 201 CHINA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 202 CHINA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 203 CHINA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 204 CHINA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 205 CHINA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 206 CHINA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 207 CHINA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.2 JAPAN
12.4.2.1 Increased research funding to create growth opportunities for NGS-based studies
TABLE 208 JAPAN: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 209 JAPAN: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 210 JAPAN: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 211 JAPAN: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 212 JAPAN: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 213 JAPAN: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 214 JAPAN: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.3 INDIA
12.4.3.1 Decreasing sequencing costs and growing prevalence of target diseases to support market
TABLE 215 INDIA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 216 INDIA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 217 INDIA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 218 INDIA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 219 INDIA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 220 INDIA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 221 INDIA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.4 AUSTRALIA
12.4.4.1 Increasing use of NGS platforms by academic institutes to propel market
TABLE 222 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 223 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 224 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 225 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 226 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 227 AUSTRALIA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 228 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.5 SOUTH KOREA
12.4.5.1 Increasing spending by government on NGS research to augment market
TABLE 229 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 230 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 231 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 232 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 233 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 234 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.6 REST OF ASIA PACIFIC
TABLE 236 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 237 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 238 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 239 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 240 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 241 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 242 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.7 ASIA PACIFIC: IMPACT OF RECESSION
12.5 LATIN AMERICA
TABLE 243 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 244 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 245 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 246 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 247 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 248 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 249 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 250 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.1 BRAZIL
12.5.1.1 Rising focus on clinical genomics to drive demand for NGS
TABLE 251 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 252 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 253 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 254 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 255 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 256 BRAZIL: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 257 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.2 MEXICO
12.5.2.1 Growing biotechnology infrastructure development to support market
TABLE 258 MEXICO: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 259 MEXICO: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 260 MEXICO: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 261 MEXICO: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 262 MEXICO: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 263 MEXICO: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 264 MEXICO: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.3 REST OF LATIN AMERICA
TABLE 265 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 266 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 267 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 268 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 269 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 270 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 271 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.4 LATIN AMERICA: IMPACT OF RECESSION
12.6 MIDDLE EAST & AFRICA
12.6.1 INTRODUCTION OF COST-EFFECTIVE AND PORTABLE NGS TECHNOLOGIES TO STIMULATE MARKET
TABLE 272 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 273 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION)
TABLE 274 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION)
TABLE 275 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION)
TABLE 276 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 277 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 278 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY STRATEGIES ADOPTED BY MARKET PLAYERS
TABLE 279 NGS SAMPLE PREPARATION MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
13.3 REVENUE SHARE ANALYSIS (TOP 5 PLAYERS)
FIGURE 31 REVENUE ANALYSIS FOR TOP 5 COMPANIES (2019?2021)
13.4 MARKET SHARE ANALYSIS (2022)
FIGURE 32 NGS SAMPLE PREPARATION MARKET: MARKET SHARE ANALYSIS OF TOP 5 PLAYERS (2022)
13.5 COMPANY EVALUATION QUADRANT
FIGURE 33 NGS SAMPLE PREPARATION MARKET: COMPANY EVALUATION MATRIX (2022)
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
13.6.1 PROGRESSIVE COMPANIES
13.6.2 STARTING BLOCKS
13.6.3 RESPONSIVE COMPANIES
13.6.4 DYNAMIC COMPANIES
FIGURE 34 NGS SAMPLE PREPARATION MARKET: START-UPS/SMES EVALUATION QUADRANT (2022)
13.7 COMPETITIVE BENCHMARKING
13.7.1 DETAILED LIST OF START-UPS/SMES
TABLE 280 NGS SAMPLE PREPARATION MARKET: DETAILED LIST OF START-UPS/SMES
13.7.2 COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES)
TABLE 281 NGS SAMPLE PREPARATION MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES]
13.8 COMPETITIVE SCENARIO AND TRENDS
13.8.1 KEY DEALS
TABLE 282 NGS SAMPLE PREPARATION MARKET: KEY DEALS
13.8.2 KEY PRODUCT LAUNCHES
TABLE 283 NGS SAMPLE PREPARATION MARKET: KEY PRODUCT LAUNCHES
13.8.3 KEY EXPANSIONS
TABLE 284 NGS SAMPLE PREPARATION MARKET: KEY EXPANSIONS
14 COMPANY PROFILES
14.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 ILLUMINA, INC.
TABLE 285 ILLUMINA, INC.: COMPANY OVERVIEW
FIGURE 35 ILLUMINA, INC.: COMPANY SNAPSHOT (2021)
14.1.2 THERMO FISHER SCIENTIFIC INC.
TABLE 286 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
14.1.3 F. HOFFMANN-LA ROCHE LTD.
TABLE 287 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
14.1.4 PERKINELMER INC.
TABLE 288 PERKINELMER INC.: COMPANY OVERVIEW
FIGURE 38 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
14.1.5 AGILENT TECHNOLOGIES, INC.
TABLE 289 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
14.1.6 DANAHER
TABLE 290 DANAHER: COMPANY OVERVIEW
14.1.7 BECTON, DICKINSON AND COMPANY
TABLE 291 BECTON, DICKINSON, AND COMPANY: COMPANY OVERVIEW
FIGURE 41 BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT (2021)
14.1.8 QIAGEN
TABLE 292 QIAGEN: COMPANY OVERVIEW
FIGURE 42 QIAGEN: COMPANY SNAPSHOT (2021)
14.1.9 MERCK KGAA
TABLE 293 MERCK KGAA: COMPANY OVERVIEW
FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT (2021)
14.1.10 BIO-RAD LABORATORIES, INC.
TABLE 294 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
14.1.11 PROMEGA CORPORATION
TABLE 295 PROMEGA CORPORATION: COMPANY OVERVIEW
14.1.12 EUROFINS SCIENTIFIC
TABLE 296 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
FIGURE 45 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
14.1.13 BGI
TABLE 297 BGI: COMPANY OVERVIEW
14.1.14 10X GENOMICS
TABLE 298 10X GENOMICS: COMPANY OVERVIEW
FIGURE 46 10X GENOMICS: COMPANY SNAPSHOT (2021)
14.1.15 SYSMEX CORPORATION
TABLE 299 SYSMEX CORPORATION: COMPANY OVERVIEW
FIGURE 47 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
14.2 OTHER PLAYERS
14.2.1 PSOMAGEN
14.2.2 ZYMO RESEARCH CORPORATION
14.2.3 TAKARA BIO INC.
14.2.4 NOVOGENE CO., LTD.
14.2.5 NEW ENGLAND BIOLABS
14.2.6 TECAN TRADING AG
14.2.7 OXFORD NANOPORE TECHNOLOGIES PLC
14.2.8 PACBIO
14.2.9 MEDGENOME
14.2.10 SWIFT BIOSCIENCES INC.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 DISCUSSION GUIDE
15.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.2 CUSTOMIZATION OPTIONS
15.3 RELATED REPORTS
15.4 AUTHOR DETAILS
